| __timestamp | Ligand Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 55402000 | 519428000 |
| Thursday, January 1, 2015 | 66107000 | 906794000 |
| Friday, January 1, 2016 | 103402000 | 1491717000 |
| Sunday, January 1, 2017 | 135736000 | 2213533000 |
| Monday, January 1, 2018 | 245116000 | 2638058000 |
| Tuesday, January 1, 2019 | 108935000 | 3615063000 |
| Wednesday, January 1, 2020 | 156000000 | 5469383000 |
| Friday, January 1, 2021 | 214957000 | 6670200000 |
| Saturday, January 1, 2022 | 143418000 | 7850400000 |
| Sunday, January 1, 2023 | 96265000 | 8607000000 |
| Monday, January 1, 2024 | 9489600000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceuticals, Vertex Pharmaceuticals Incorporated and Ligand Pharmaceuticals Incorporated have showcased intriguing trends in their gross profit margins over the past decade. From 2014 to 2023, Vertex Pharmaceuticals has demonstrated a remarkable growth trajectory, with its gross profit surging by over 1,500%, reaching a peak in 2023. This growth underscores Vertex's strategic advancements and market adaptability.
Conversely, Ligand Pharmaceuticals has experienced a more modest increase, with its gross profit peaking in 2018 before experiencing fluctuations. Despite these variations, Ligand's gross profit in 2023 remains approximately 74% higher than in 2014, highlighting its resilience in a competitive market.
These trends reflect broader industry dynamics, where innovation and strategic positioning play pivotal roles in financial performance. As the pharmaceutical sector continues to evolve, these companies' trajectories offer valuable insights into the industry's future.
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Ligand Pharmaceuticals Incorporated
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and Zoetis Inc.
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and BioMarin Pharmaceutical Inc.
Gross Profit Trends Compared: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated and Exelixis, Inc.: A Detailed Gross Profit Analysis
Comparing Cost of Revenue Efficiency: Vertex Pharmaceuticals Incorporated vs Ligand Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Biogen Inc. or Ligand Pharmaceuticals Incorporated
United Therapeutics Corporation vs Ligand Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Catalent, Inc. vs Ligand Pharmaceuticals Incorporated
Gross Profit Comparison: Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Trends